These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18951019)

  • 1. 2-Alkylamino- and alkoxy-substituted 2-amino-1,3,4-oxadiazoles-O-Alkyl benzohydroxamate esters replacements retain the desired inhibition and selectivity against MEK (MAP ERK kinase).
    Warmus JS; Flamme C; Zhang LY; Barrett S; Bridges A; Chen H; Gowan R; Kaufman M; Sebolt-Leopold J; Leopold W; Merriman R; Ohren J; Pavlovsky A; Przybranowski S; Tecle H; Valik H; Whitehead C; Zhang E
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6171-4. PubMed ID: 18951019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles.
    Kumar D; Patel G; Johnson EO; Shah K
    Bioorg Med Chem Lett; 2009 May; 19(10):2739-41. PubMed ID: 19376704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of hydroxamate-based histone deacetylase inhibitors containing 1,2,4-oxadiazole moiety core with antitumor activities.
    Yang F; Shan P; Zhao N; Ge D; Zhu K; Jiang CS; Li P; Zhang H
    Bioorg Med Chem Lett; 2019 Jan; 29(1):15-21. PubMed ID: 30455152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, structure, and bioactivity of N'-substituted benzylidene-3,4,5-trimethoxybenzohydrazide and 3-acetyl-2-substituted phenyl-5-(3,4,5-trimethoxyphenyl)-2,3-dihydro-1,3,4-oxadiazole derivatives.
    Jin L; Chen J; Song B; Chen Z; Yang S; Li Q; Hu D; Xu R
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5036-40. PubMed ID: 16876405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An efficient synthesis and biological study of novel indolyl-1,3,4-oxadiazoles as potent anticancer agents.
    Kumar D; Sundaree S; Johnson EO; Shah K
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4492-4. PubMed ID: 19559607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Trifluoroacetylthiophene oxadiazoles as potent and selective class II human histone deacetylase inhibitors.
    Muraglia E; Altamura S; Branca D; Cecchetti O; Ferrigno F; Orsale MV; Palumbi MC; Rowley M; Scarpelli R; Steinkühler C; Jones P
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6083-7. PubMed ID: 18930398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and preliminary biological evaluation of new hydroxamate histone deacetylase inhibitors as potential antileukemic agents.
    Guandalini L; Cellai C; Laurenzana A; Scapecchi S; Paoletti F; Romanelli MN
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5071-4. PubMed ID: 18723349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of 3-aryl-5-aryl-1,2,4-oxadiazoles as a new series of apoptosis inducers. 2. Identification of more aqueous soluble analogs as potential anticancer agents.
    Kemnitzer W; Kuemmerle J; Zhang HZ; Kasibhatla S; Tseng B; Drewe J; Cai SX
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4410-5. PubMed ID: 19500976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural modifications of N-arylamide oxadiazoles: Identification of N-arylpiperidine oxadiazoles as potent and selective agonists of CB2.
    DiMauro EF; Buchanan JL; Cheng A; Emkey R; Hitchcock SA; Huang L; Huang MY; Janosky B; Lee JH; Li X; Martin MW; Tomlinson SA; White RD; Zheng XM; Patel VF; Fremeau RT
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4267-74. PubMed ID: 18640038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of novel compounds with conjugated structure as anti-tumor agents.
    Su H; Nebbioso A; Carafa V; Chen Y; Yang B; Altucci L; You Q
    Bioorg Med Chem; 2008 Sep; 16(17):7992-8002. PubMed ID: 18701301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel 5-(2-hydroxyphenyl)-3-substituted-2,3-dihydro-1,3,4-oxadiazole-2-thione derivatives: promising anticancer agents.
    Aboraia AS; Abdel-Rahman HM; Mahfouz NM; El-Gendy MA
    Bioorg Med Chem; 2006 Feb; 14(4):1236-46. PubMed ID: 16242340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, X-ray crystal structure study, and cytostatic and antiviral evaluation of the novel cycloalkyl-N-aryl-hydroxamic acids.
    Barbarić M; Ursić S; Pilepić V; Zorc B; Hergold-Brundić A; Nagl A; Grdisa M; Pavelić K; Snoeck R; Andrei G; Balzarini J; De Clercq E; Mintas M
    J Med Chem; 2005 Feb; 48(3):884-7. PubMed ID: 15689173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of a novel series of 1,3,4-oxadiazole bearing N-methyl-4-(trifluoromethyl)phenyl pyrazole moiety as cytotoxic agents.
    Puthiyapurayil P; Poojary B; Chikkanna C; Buridipad SK
    Eur J Med Chem; 2012 Jul; 53():203-10. PubMed ID: 22542958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of 1,2,5-oxadiazole N-oxide derivatives as hypoxia-selective cytotoxins.
    Monge A; López de Ceráin A; Ezpeleta O; Cerecetto H; Dias E; Di Maio R; González M; Onetto S; Seoane G; Suescun L; Mariezcurrena R
    Pharmazie; 1998 Nov; 53(11):758-64. PubMed ID: 9853357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and cytotoxic evaluation of combretafurazans.
    Tron GC; Pagliai F; Del Grosso E; Genazzani AA; Sorba G
    J Med Chem; 2005 May; 48(9):3260-8. PubMed ID: 15857132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and pro-apoptotic antitumour properties of indole-based 3,5-disubstituted oxadiazoles.
    Ziedan NI; Stefanelli F; Fogli S; Westwell AD
    Eur J Med Chem; 2010 Oct; 45(10):4523-30. PubMed ID: 20705365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-anilino-5-carboxamido-2-pyridone derivatives as noncompetitive inhibitors of mitogen-activated protein kinase kinase.
    Spicer JA; Rewcastle GW; Kaufman MD; Black SL; Plummer MS; Denny WA; Quin J; Shahripour AB; Barrett SD; Whitehead CE; Milbank JB; Ohren JF; Gowan RC; Omer C; Camp HS; Esmaeil N; Moore K; Sebolt-Leopold JS; Pryzbranowski S; Merriman RL; Ortwine DF; Warmus JS; Flamme CM; Pavlovsky AG; Tecle H
    J Med Chem; 2007 Oct; 50(21):5090-102. PubMed ID: 17880056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A facile synthesis of novel bis-(indolyl)-1,3,4-oxadiazoles as potent cytotoxic agents.
    Kumar D; Arun V; Maruthi Kumar N; Acosta G; Noel B; Shah K
    ChemMedChem; 2012 Nov; 7(11):1915-20. PubMed ID: 22997171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial transformation of trichostatin A to 2,3-dihydrotrichostatin A.
    Park JW; Park SR; Han AR; Ban YH; Yoo YJ; Kim EJ; Kim E; Yoon YJ
    J Nat Prod; 2011 May; 74(5):1272-4. PubMed ID: 21504214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.